Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery

Michael Eldar*, Gerald Hollander, Nancy Schulhoff, Elliot Ohlstein, Alvin Greengart, Edgar Lichstein, Jacob Shani

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Chest pain is one of the hallmarks of myocardial ischemia (angina pectoris). Exact mechanisms responsible for the production of ischemia-induced pain are not clear.1 A prevailing hypothesis postulates the activation of peripheral nociceptive receptors by substances originating in the ischemic myocardium.2-4 Several investigators have suggested that bradykinin, one of the most potent natural algesic substances, may be responsible for anginal pain.5,6 Kimura et al7 found that coronary ligation in the dog induces a rapid increase in the coronary sinus level of bradykinin. The relation of bradykmin to myocardial ischemic pain in humans has not been previously reported. We studied the plasma bradykinin level in the great cardiac vein during transient myocardial ischemia induced by balloon angioplasty of the left anterior descending coronary artery in humans.

Original languageEnglish
Pages (from-to)1621-1623
Number of pages3
JournalAmerican Journal of Cardiology
Volume70
Issue number20
DOIs
StatePublished - 15 Dec 1992
Externally publishedYes

Fingerprint

Dive into the research topics of 'Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery'. Together they form a unique fingerprint.

Cite this